June/July 2009, Vol 2, No 4

Regulatory

Applying Evidence for Medical Technologies: Closing the Gap between R&D and Decision Maker Needs
Interview with Sean R. Tunis, MD, MSc
Stakeholder Perspective by F. Randy Vogenberg, RPh, PhD

Business

The Working Patient with Cancer: Implications for Payers and Employers
Grant D. Lawless, BSPharm, MD, FACP
Stakeholder Perspective by Gary M. Owens, MD
Lower Copay and Oral Administration: Predictors of First-Fill Adherence to New Asthma Prescriptions
Zackary Berger, MD, PhD
; William Kimbrough, MD
; Colleen Gillespie, PhD
; Joseph A. Boscarino, PhD, MPH
; G. Craig Wood, MS
; Zhengmin Qian, MD, PhD
; J. B. Jones, PhD, MBA
; Nirav R. Shah, MD, MPH
Stakeholder Perspective by Ronald A. Lyon, MS

Clinical

Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder, 1998-2002
Jeffery A. Demland, MS
; Yonghua Jing, BPharm, PhD
; Christina M. L. Kelton, PhD
; Jeff Jianfei Guo, MS, BPharm, PhD
; Hong Li, PhD
; Patricia R. Wigle, PharmD
Stakeholder Perspective by Renee Rizzo Fleming, RPh, MBA

Editorial

Prioritizing Healthcare Resources to Keep the Baby Boomers Out of Nursing Homes
Robert E. Henry

Commentary

The View from Washington: Healthcare Reform
John Gorman
EXECUTIVE SUMMARIES

Generic Drug Trends

Biosimilars Policy Forum: Perspectives on Safety and Efficacy of Future Products
F. Randy Vogenberg, RPh, PhD

Industry Trends

Payer Perspectives on Healthcare Reform
Peyton Howell, MHA
; Gene Reeder, RPh, PhD
; Timothy S. Regan, BPharm, RPh, CPh

Overview

Workplace Wellness and Disease Prevention: Focus on Chronic Obstructive Pulmonary Disease
COPD Management in a Value-Based Healthcare System
Interview with David Tinkelman, MD
The Economic Burden of COPD in the Workplace
Interview with William B. Bunn, III, MD, JD, MPH